000250 - Samchundang Pharm

000250 Summary
Biopharma
Stock Price & Overview
₩157,000 +1,600 (+1.03%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩157,000  ≈ US$112  ·  Market cap ₩3.7tn (≈ $2.6bn)

000250 Stock Price

500K1.00Mprev 155Kpeak 1.18MOctNovDecJan ’26FebMarAprMayJunJulAugSep157K
52 Week Range
₩126,500₩1,184,000
Day Range
₩155,300₩158,700
Market Cap
₩3.7tn
P/E (TTM)
144.57x
P/B
9.19x
P/S (TTM)
14.17x
P/CF (TTM)
141.20x
Volume
66,500
Shares Out
23.5M
Prev. Close
₩155,400
vs 52W High
-86.7%
Multiples use the close and the financials that were public on that date (DART), the same series as the Valuation tab — they are not vendor figures.

000250 Analysis

See all »

Nothing written yet for this company.

000250 News

See all »

No news written yet.

000250 Momentum

Period000250KOSDAQDifference
1 week-8.2%-3.0%-5.2%
1 month-6.2%+4.2%-10.4%
3 months-49.3%-22.5%-26.8%
6 months-75.7%-16.9%-58.8%
Year to date-32.5%-12.1%-20.4%
1 year-21.5%+1.0%-22.5%

Closed at 3% of the way from its 52-week low (₩126,500) to its 52-week high (₩1,184,000).

Price return on KRX closes, KOSDAQ on the same dates, no dividends. A period starts at the last trading day on or before the calendar date.

000250 Filings

See all »
DART

5% Ownership Report — Large Holdings

Ownership08/14/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Material matter affecting investment judgment (clinical trial plan approval)

Filing08/05/26title translated
DART

Material matter affecting investment judgment (clinical trial plan applied for)

Filing08/05/26title translated
Korean issuers file to DART, not the SEC. Titles are translated; where kstock has read the filing the row carries the explanation.

000250 Company Profile

Samchundang Pharm makes prescription medicines in South Korea. It is listed on KOSDAQ, was founded in 1943, is based in Gyeonggi, and has revenue of hundreds of billions of won.

SectorBiopharmaEmployees
MarketKOSDAQFounded1943
Korean name삼천당제약Head officeGyeonggi

Similar to 000250

SymbolLast Price
000100Yuhan Corporation₩81,400
+0.0%
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.